Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Bruchim

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Archives of Physiology and Biochemistry|June 3, 2009
The insulin-like growth factor-I receptor as an oncogeneHaim Werner, Ilan Bruchim
BMC Medicine|January 7, 2010
Basic and clinical significance of IGF-I-induced signatures in cancerHaim Werner, Ilan Bruchim
Expert Opinion on Therapeutic Targets|January 9, 2013
Targeting IGF-1 signaling pathways in gynecologic malignanciesIlan Bruchim, Haim Werner
The Lancet. Oncology|November 28, 2012
IGF-1 and BRCA1 signalling pathways in familial cancerHaim Werner, Ilan Bruchim
Frontiers in Endocrinology|June 7, 2014
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting ApproachesIlan Bruchim, Rive Sarfstein, Haim Werner
Expert Opinion on Therapeutic Targets|August 12, 2009
Targeting the IGF1 axis in cancer proliferationIlan Bruchim, Zohar Attias, Haim Werner
Gynecologic Oncology|September 10, 2002
Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancerIlan Bruchim, Marco Altaras, Ami Fishman
Expert Opinion on Investigational Drugs|November 17, 2019
Investigational IGF1R inhibitors in early stage clinical trials for cancer therapyHaim Werner, Rive Sarfstein, Ilan Bruchim
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 24, 2012
Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancerIlan Bruchim, Osnat Jarchowsky-Dolberg, Ami Fishman
Molecular Cancer|February 20, 2018
Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathwayHaim Werner, Shilhav Meisel-Sharon, Ilan Bruchim
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Archives of Physiology and Biochemistry|June 3, 2009
The insulin-like growth factor-I receptor as an oncogeneHaim Werner, Ilan Bruchim
BMC Medicine|January 7, 2010
Basic and clinical significance of IGF-I-induced signatures in cancerHaim Werner, Ilan Bruchim
Expert Opinion on Therapeutic Targets|January 9, 2013
Targeting IGF-1 signaling pathways in gynecologic malignanciesIlan Bruchim, Haim Werner
The Lancet. Oncology|November 28, 2012
IGF-1 and BRCA1 signalling pathways in familial cancerHaim Werner, Ilan Bruchim
Frontiers in Endocrinology|June 7, 2014
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting ApproachesIlan Bruchim, Rive Sarfstein, Haim Werner
Expert Opinion on Therapeutic Targets|August 12, 2009
Targeting the IGF1 axis in cancer proliferationIlan Bruchim, Zohar Attias, Haim Werner
Gynecologic Oncology|September 10, 2002
Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancerIlan Bruchim, Marco Altaras, Ami Fishman
Expert Opinion on Investigational Drugs|November 17, 2019
Investigational IGF1R inhibitors in early stage clinical trials for cancer therapyHaim Werner, Rive Sarfstein, Ilan Bruchim
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 24, 2012
Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancerIlan Bruchim, Osnat Jarchowsky-Dolberg, Ami Fishman
Molecular Cancer|February 20, 2018
Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathwayHaim Werner, Shilhav Meisel-Sharon, Ilan Bruchim
Pageof 9